13-109179569-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001198950.3(MYO16):c.5351G>A(p.Arg1784Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000948 in 1,613,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001198950.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO16 | NM_001198950.3 | c.5351G>A | p.Arg1784Gln | missense_variant | 34/35 | ENST00000457511.7 | NP_001185879.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO16 | ENST00000457511.7 | c.5351G>A | p.Arg1784Gln | missense_variant | 34/35 | 1 | NM_001198950.3 | ENSP00000401633.3 | ||
MYO16 | ENST00000356711.7 | c.5285G>A | p.Arg1762Gln | missense_variant | 34/35 | 1 | ENSP00000349145.2 | |||
MYO16-AS1 | ENST00000439299.1 | n.30-12265C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000135 AC: 34AN: 251460Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135904
GnomAD4 exome AF: 0.0000862 AC: 126AN: 1461590Hom.: 0 Cov.: 30 AF XY: 0.0000784 AC XY: 57AN XY: 727102
GnomAD4 genome AF: 0.000177 AC: 27AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2024 | The c.5351G>A (p.R1784Q) alteration is located in exon 34 (coding exon 34) of the MYO16 gene. This alteration results from a G to A substitution at nucleotide position 5351, causing the arginine (R) at amino acid position 1784 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at